SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '59B'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DMA_A_NCAA700_0 (EXOTOXIN A) |
5dcz | TANKYRASE-2 (Homosapiens) | 4 / 7 | HIS A1031GLY A1032TYR A1060TYR A1071 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-4.3A)59B A1203 (-3.3A) | 0.16A | 1dmaA-5dczA:6.1 | 1dmaA-5dczA:17.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DMA_A_NCAA700_0 (EXOTOXIN A) |
5dcz | TANKYRASE-2 (Homosapiens) | 4 / 7 | HIS A1031GLY A1032TYR A1071GLU A1138 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-3.3A)59B A1203 (-3.7A) | 0.75A | 1dmaA-5dczA:6.1 | 1dmaA-5dczA:17.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DMA_B_NCAB700_0 (EXOTOXIN A) |
5dcz | TANKYRASE-2 (Homosapiens) | 5 / 6 | HIS A1031GLY A1032TYR A1060ALA A1062TYR A1071 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-4.3A)59B A1203 (-3.5A)59B A1203 (-3.3A) | 0.35A | 1dmaB-5dczA:5.5 | 1dmaB-5dczA:17.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DMA_B_NCAB700_0 (EXOTOXIN A) |
5dcz | TANKYRASE-2 (Homosapiens) | 4 / 6 | HIS A1031GLY A1032TYR A1071GLU A1138 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-3.3A)59B A1203 (-3.7A) | 0.55A | 1dmaB-5dczA:5.5 | 1dmaB-5dczA:17.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AJV_L_COCL501_1 (ANTIBODY 7A1 FAB') |
5dcz | TANKYRASE-2 (Homosapiens) | 4 / 7 | ALA A1135ARG A 980TYR A1050TYR A1060 | NonePO4 A1202 (-4.9A)59B A1203 ( 4.3A)59B A1203 (-4.3A) | 1.20A | 2ajvH-5dczA:undetectable2ajvL-5dczA:undetectable | 2ajvH-5dczA:21.542ajvL-5dczA:19.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JAY_A_SAMA1102_0 (STRUCTURAL PROTEINVP3) |
5dcz | TANKYRASE-2 (Homosapiens) | 5 / 12 | TYR A1071ILE A1051GLY A1052GLY A1053ILE A1075 | 59B A1203 (-3.3A)NoneNoneNone59B A1203 (-4.8A) | 1.04A | 3jayA-5dczA:undetectable | 3jayA-5dczA:12.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3U9H_A_NCAA1163_0 (TANKYRASE-2) |
5dcz | TANKYRASE-2 (Homosapiens) | 8 / 8 | HIS A1031GLY A1032TYR A1060ALA A1062LYS A1067SER A1068TYR A1071GLU A1138 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-4.3A)59B A1203 (-3.5A)PO4 A1202 (-2.7A)59B A1203 (-2.8A)59B A1203 (-3.3A)59B A1203 (-3.7A) | 0.23A | 3u9hA-5dczA:37.4 | 3u9hA-5dczA:96.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3U9H_B_NCAB1164_0 (TANKYRASE-2) |
5dcz | TANKYRASE-2 (Homosapiens) | 8 / 8 | HIS A1031GLY A1032TYR A1060ALA A1062LYS A1067SER A1068TYR A1071GLU A1138 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-4.3A)59B A1203 (-3.5A)PO4 A1202 (-2.7A)59B A1203 (-2.8A)59B A1203 (-3.3A)59B A1203 (-3.7A) | 0.23A | 3u9hB-5dczA:37.2 | 3u9hB-5dczA:96.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AE1_A_NCAA1536_0 (DIPHTHERIA TOXIN) |
5dcz | TANKYRASE-2 (Homosapiens) | 4 / 6 | HIS A1031GLY A1032TYR A1060TYR A1071 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-4.3A)59B A1203 (-3.3A) | 0.29A | 4ae1A-5dczA:6.8 | 4ae1A-5dczA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AE1_A_NCAA1536_0 (DIPHTHERIA TOXIN) |
5dcz | TANKYRASE-2 (Homosapiens) | 4 / 6 | HIS A1031GLY A1032TYR A1071GLU A1138 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-3.3A)59B A1203 (-3.7A) | 0.77A | 4ae1A-5dczA:6.8 | 4ae1A-5dczA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AE1_B_NCAB1536_0 (DIPHTHERIA TOXIN) |
5dcz | TANKYRASE-2 (Homosapiens) | 4 / 5 | HIS A1031GLY A1032TYR A1060TYR A1071 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-4.3A)59B A1203 (-3.3A) | 0.31A | 4ae1B-5dczA:5.0 | 4ae1B-5dczA:18.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AE1_B_NCAB1536_0 (DIPHTHERIA TOXIN) |
5dcz | TANKYRASE-2 (Homosapiens) | 4 / 5 | HIS A1031GLY A1032TYR A1071GLU A1138 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-3.3A)59B A1203 (-3.7A) | 0.76A | 4ae1B-5dczA:5.0 | 4ae1B-5dczA:18.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4BJC_A_RPBA2162_1 (TANKYRASE-2) |
5dcz | TANKYRASE-2 (Homosapiens) | 8 / 8 | HIS A1031GLY A1032TYR A1060ALA A1062LYS A1067SER A1068TYR A1071GLU A1138 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-4.3A)59B A1203 (-3.5A)PO4 A1202 (-2.7A)59B A1203 (-2.8A)59B A1203 (-3.3A)59B A1203 (-3.7A) | 0.21A | 4bjcA-5dczA:34.5 | 4bjcA-5dczA:96.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HYF_A_NCAA1201_0 (TANKYRASE-2) |
5dcz | TANKYRASE-2 (Homosapiens) | 6 / 7 | HIS A1031GLY A1032ALA A1062SER A1068TYR A1071GLU A1138 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-3.5A)59B A1203 (-2.8A)59B A1203 (-3.3A)59B A1203 (-3.7A) | 0.90A | 4hyfA-5dczA:32.9 | 4hyfA-5dczA:96.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HYF_A_NCAA1201_0 (TANKYRASE-2) |
5dcz | TANKYRASE-2 (Homosapiens) | 6 / 7 | HIS A1031GLY A1032TYR A1060ALA A1062SER A1068TYR A1071 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-4.3A)59B A1203 (-3.5A)59B A1203 (-2.8A)59B A1203 (-3.3A) | 0.44A | 4hyfA-5dczA:32.9 | 4hyfA-5dczA:96.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HYF_B_NCAB1201_0 (TANKYRASE-2) |
5dcz | TANKYRASE-2 (Homosapiens) | 6 / 8 | HIS A1031GLY A1032ALA A1062SER A1068TYR A1071GLU A1138 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-3.5A)59B A1203 (-2.8A)59B A1203 (-3.3A)59B A1203 (-3.7A) | 0.90A | 4hyfB-5dczA:32.9 | 4hyfB-5dczA:96.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HYF_B_NCAB1201_0 (TANKYRASE-2) |
5dcz | TANKYRASE-2 (Homosapiens) | 7 / 8 | HIS A1031GLY A1032TYR A1060ALA A1062LYS A1067SER A1068TYR A1071 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-4.3A)59B A1203 (-3.5A)PO4 A1202 (-2.7A)59B A1203 (-2.8A)59B A1203 (-3.3A) | 0.50A | 4hyfB-5dczA:32.9 | 4hyfB-5dczA:96.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HYF_C_NCAC1201_0 (TANKYRASE-2) |
5dcz | TANKYRASE-2 (Homosapiens) | 5 / 8 | HIS A1031GLY A1032SER A1068TYR A1071GLU A1138 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-2.8A)59B A1203 (-3.3A)59B A1203 (-3.7A) | 0.78A | 4hyfC-5dczA:32.4 | 4hyfC-5dczA:96.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HYF_C_NCAC1201_0 (TANKYRASE-2) |
5dcz | TANKYRASE-2 (Homosapiens) | 6 / 8 | HIS A1031GLY A1032TYR A1060ALA A1062SER A1068TYR A1071 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-4.3A)59B A1203 (-3.5A)59B A1203 (-2.8A)59B A1203 (-3.3A) | 0.46A | 4hyfC-5dczA:32.4 | 4hyfC-5dczA:96.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HYF_C_NCAC1201_0 (TANKYRASE-2) |
5dcz | TANKYRASE-2 (Homosapiens) | 6 / 8 | HIS A1031GLY A1032TYR A1060LYS A1067SER A1068TYR A1071 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-4.3A)PO4 A1202 (-2.7A)59B A1203 (-2.8A)59B A1203 (-3.3A) | 1.08A | 4hyfC-5dczA:32.4 | 4hyfC-5dczA:96.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RV6_A_RPBA1103_1 (POLY [ADP-RIBOSE]POLYMERASE 1) |
5dcz | TANKYRASE-2 (Homosapiens) | 6 / 11 | HIS A1031GLY A1032ALA A1062SER A1068TYR A1071GLU A1138 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-3.5A)59B A1203 (-2.8A)59B A1203 (-3.3A)59B A1203 (-3.7A) | 0.91A | 4rv6A-5dczA:19.4 | 4rv6A-5dczA:22.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RV6_A_RPBA1103_1 (POLY [ADP-RIBOSE]POLYMERASE 1) |
5dcz | TANKYRASE-2 (Homosapiens) | 6 / 11 | HIS A1031GLY A1032TYR A1060ALA A1062LYS A1067SER A1068 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-4.3A)59B A1203 (-3.5A)PO4 A1202 (-2.7A)59B A1203 (-2.8A) | 1.11A | 4rv6A-5dczA:19.4 | 4rv6A-5dczA:22.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RV6_A_RPBA1103_1 (POLY [ADP-RIBOSE]POLYMERASE 1) |
5dcz | TANKYRASE-2 (Homosapiens) | 6 / 11 | HIS A1031GLY A1032TYR A1060ALA A1062SER A1068TYR A1071 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-4.3A)59B A1203 (-3.5A)59B A1203 (-2.8A)59B A1203 (-3.3A) | 0.43A | 4rv6A-5dczA:19.4 | 4rv6A-5dczA:22.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RV6_B_RPBB1103_1 (POLY [ADP-RIBOSE]POLYMERASE 1) |
5dcz | TANKYRASE-2 (Homosapiens) | 6 / 11 | HIS A1031GLY A1032ALA A1062SER A1068TYR A1071GLU A1138 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-3.5A)59B A1203 (-2.8A)59B A1203 (-3.3A)59B A1203 (-3.7A) | 0.91A | 4rv6B-5dczA:19.4 | 4rv6B-5dczA:22.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RV6_B_RPBB1103_1 (POLY [ADP-RIBOSE]POLYMERASE 1) |
5dcz | TANKYRASE-2 (Homosapiens) | 6 / 11 | HIS A1031GLY A1032TYR A1060ALA A1062LYS A1067SER A1068 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-4.3A)59B A1203 (-3.5A)PO4 A1202 (-2.7A)59B A1203 (-2.8A) | 1.11A | 4rv6B-5dczA:19.4 | 4rv6B-5dczA:22.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RV6_B_RPBB1103_1 (POLY [ADP-RIBOSE]POLYMERASE 1) |
5dcz | TANKYRASE-2 (Homosapiens) | 6 / 11 | HIS A1031GLY A1032TYR A1060ALA A1062SER A1068TYR A1071 | 59B A1203 (-4.1A)59B A1203 (-4.1A)59B A1203 (-4.3A)59B A1203 (-3.5A)59B A1203 (-2.8A)59B A1203 (-3.3A) | 0.42A | 4rv6B-5dczA:19.4 | 4rv6B-5dczA:22.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HA9_B_TP0B406_1 (POLY [ADP-RIBOSE]POLYMERASE 1) |
5dcz | TANKYRASE-2 (Homosapiens) | 6 / 9 | HIS A1031SER A1033ILE A1039TYR A1060SER A1068TYR A1071 | 59B A1203 (-4.1A)59B A1203 (-3.5A)None59B A1203 (-4.3A)59B A1203 (-2.8A)59B A1203 (-3.3A) | 0.65A | 5ha9B-5dczA:17.4 | 5ha9B-5dczA:22.47 |